Department of Medicine

Department of Medicine

  Division of Cardiology

[Return To Index page]
photo Evan C. Adelstein, MD

Assistant Professor of Medicine


Phone: 412-647-6272

Office: 200 Lothrop Street
PUH B535
Pittsburgh, PA 15213
Phone: 412-647-6272
Fax: 412-647-7979
Administrative Assistant:
Raquel Barilla
Phone: 412-647-6272
Education and Training
AB, Princeton University, 1995
M.D., Georgetown University School of Medicine, 1999
Internal Medicine Residency, Hospital of the University of Pennsylvania, 2002
Cardiovascular Diseases Fellowship, University of Pittsburgh, 2005
Cardiac Electrophysiology, University of Pittsburgh, 2007
Research Interest
The role of cardiac resynchronization therapy in patient populations not studied in large-scale clinical trials.
The electromechanical effects of anti-arrhythmic drug therapy.
Use of the wearable cardioverter-defibrillator.
Clinical Interest
Supraventricular tachycardia diagnosis and treatment
Atrial fibrillation treatment
Ventricular tachycardia treatment
Implantable cardiac rhythm devices, including implantation and optimal programming
Anti-arrhythmic drugs
Educational Interest
Clinical decision-making
Rational use of health care resources
Capabilities of implantable cardiac rhythm devices
Invasive electrophysiology procedures
For my complete bibliography, Click Here.
Selected Publications:
Singh, M., Jain, S.K., Wang, N., Saba, S., Voigt, A., Adelstein, E.C. Wearable Cardioverter-Defibrillator in Patients With Newly Diagnosed Cardiomyopathy: A Decade-Long Single Center Experience. J Am Coll Cardiol. 2015; 66(23): 2607-13.
Adelstein, E.C., Liu, J., Schwartzman, D., Jain, S., Wang, N., Althouse, A., Gorcsan III, J., Saba, S. Clinical Outcomes in Cardiac Resynchronization Therapy-Defibrillator Recipients 80 Years of Age and Older. Europace. 2015; in press.
Adelstein, E.C., Schwartzman, D., Bazaz, R., Saba, S. Outcomes in Pacemaker-Dependent Patients Upgraded from Conventional Pacemakers to Cardiac Resynchronization Therapy-Defibrillators. Heart Rhythm. 2014; 11(6): 1008-14.
Adelstein, E.C., Alam, M.B., Schwartzman, D., Jain, S., Gorcsan III, J., Saba, S. Effect of Echocardiography-Guided Left Ventricular Lead Placement for Cardiac Resynchronization Therapy on Mortality and Risk of Defibrillator Therapy for Ventricular Arrhythmias: Results from the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region (STARTER) Trial. Am J Cardiol. 2014; 113 (9): 1518-1522.
Adelstein, E.C., Schwartzman, D., Bazaz, R., Jain, S., Saba, S. Effect of Digoxin on Shocks in Cardiac Resynchronization Therapy-Defibrillator Patients with Coronary Artery Disease. Am J Cardiol. 2013; 113: 970-975.
Adelstein, E.C., Bhattacharya, S., Simon, M., Gorcsan III, J., Saba, S. Comparison of Outcomes for Patients With Nonischemic Cardiomyopathy Taking Intravenous Inotropes Versus Those Weaned from or Never Taking Inotropes at Cardiac Resynchronization Therapy. Am J Cardiol. 2012; 110: 857-861.
Adelstein, E.C., Schwartzman, D., Gorcsan III, J., Saba, S. Predicting Hyperresponse Among Pacemaker-Dependent Non-Ischemic Cardiomyopathy Patients Upgraded to Cardiac Resynchronization. J Cardiovasc Electrophysiol. 2011; 22: 905-911.
Adelstein, E.C., Tanaka, H., Soman, P., Miske, G., Haberman, S.C., Saba, S., Gorcsan III, J. Impact of Scar Burden by SPECT Myocardial Perfusion Imaging On Patient Outcomes Following Cardiac Resynchronization Therapy. Eur Heart J. 2011; 32: 93-103.
Adelstein, E.C., Shalaby, A., Saba, S. Response to Cardiac Resynchronization Therapy in Patients with Heart Failure and Renal Insufficiency. Pacing Clin Electrophysiol. 2010; 33: 850-859.
Adelstein, E.C., Saba, S. Usefulness of Baseline Electrocardiographic QRS Complex Pattern to Predict Response to Cardiac Resynchronization. Am J Cardiology. 2009; 103: 238-242.